Catch | catch up with the schedule
Underlyingconditionsbelow:WhenbothPCV13andPPSV23areindicated,administerPCV13first.PCV13andPPSV23shouldnotbeadministeredduringsamevisit.Chronicheartdisease(particularlycyanoticcongenitalheartdiseaseandcardiacfailure);chroniclungdisease(includingasthmatreatedwithhigh-dose,oralcorticosteroids);diabetesmellitus:Age2–5yearsAnyincomplete*serieswith:3PCV13doses:1dosePCV13(atleast8weeksafteranypriorPCV13dose)Lessthan3PCV13doses:2dosesPCV13(8weeksafterthemostrecentdoseandadministered8weeksapart)Nohis...
Underlying conditions below: When both PCV13 and PPSV23 are indicated, administer PCV13 first. PCV13 and PPSV23 should not be administered during same visit.
Chronic heart disease (particularly cyanotic congenital heart disease and cardiac failure); chronic lung disease (including asthma treated with high-dose, oral corticosteroids); diabetes mellitus:
Age 2–5 years
Any incomplete* series with: 3 PCV13 doses: 1 dose PCV13 (at least 8 weeks after any prior PCV13 dose) Less than 3 PCV13 doses: 2 doses PCV13 (8 weeks after the most recent dose and administered 8 weeks apart) No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after completing all recommended PCV13 doses)Age 6–18 years
No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after completing all recommended PCV13 doses)Cerebrospinal fluid leak, cochlear implant:
Age 2–5 years
Any incomplete* series with: 3 PCV13 doses: 1 dose PCV13 (at least 8 weeks after any prior PCV13 dose) L...